https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2025-03-04 / Cancers (Basel) 2025 Mar;17(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2025-03-04 / Cancers (Basel) 2025 Mar;17(5)2025-03-04 00:00:002025-03-17 07:36:12The Complexity of Malignant Glioma Treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
Diego Alegria
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
Diego Alegria2024-09-30 11:20:172024-11-18 10:10:20IOZK Webinar auf dem World Cancer Series
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
Diego Alegria
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
Diego Alegria2024-09-12 08:29:062024-11-12 11:20:15Fachärzte Talk zur kombinierten Immun-Chemotherapie
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
arndslegers
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
arndslegers2024-07-04 10:34:312024-11-18 10:38:45Interview mit Prof. Dr. Volker Schirrmacher im Klassik Radio
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2024-03-28 / Biomedicines 2024 Mar;12(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2024-03-28 / Biomedicines 2024 Mar;12(4)2024-03-28 00:00:002024-04-30 08:35:31Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2023-11-07 17:20:492024-01-18 12:04:25Neue IOZK Veröffentlichung zum Thema Liquid Biopsy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-10-19 / Methods Cell Biol 2024;183:51-113
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-10-19 / Methods Cell Biol 2024;183:51-1132023-10-19 00:00:002024-04-20 10:47:17Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-2228
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-07-28 / Transl Cancer Res 2023 Aug;12(8):2224-22282023-07-28 00:00:002024-04-17 15:08:24Dendritic cell vaccination for glioblastoma multiforme patients: has a new milestone been reached?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-06-23 / Biomedicines 2023 Jun;11(7)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-06-23 / Biomedicines 2023 Jun;11(7)2023-06-23 00:00:002024-04-17 15:04:06The Application of Evidence-Based Medicine in Individualized Medicine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2023-02-13 / Cancers (Basel) 2023 Feb;15(4)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2023-02-13 / Cancers (Basel) 2023 Feb;15(4)2023-02-13 00:00:002023-05-30 16:20:40Individualized Multimodal Immunotherapy for Adults with IDH1 Wild-Type GBM: A Single Institute Experience